Genetic and immunological biomarkers predict metastatic disease recurrence in stage III colon cancer-Reference-Cited by-同舟云学术

Genetic and immunological biomarkers predict metastatic disease recurrence in stage III colon cancer

Published:2018-10-19 Issue:1 Volume:18 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Sperlich Andreas,Balmert Alexander,Doll Dietrich,Bauer Sabine,Franke Fabian,Keller Gisela,Wilhelm Dirk,Mur Anna,Respondek Michael,Friess Helmut,Nitsche Ulrich,Janssen Klaus-Peter^ORCID

Funder

Gesellschaft für Gastroenterologie in Bayern e.V

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-018-4940-2.pdf

Reference41 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30.

2. Nitsche U, Maak M, Schuster T, Kunzli B, Langer R, Slotta-Huspenina J, Janssen KP, Friess H, Rosenberg R. Prediction of prognosis is not improved by the seventh and latest edition of the TNM classification for colorectal cancer in a single-center collective. Ann Surg. 2011;254(5):793–800 discussion 800-791.

3. Papamichael D, Audisio RA, Glimelius B, de Gramont A, Glynne-Jones R, Haller D, Kohne CH, Rostoft S, Lemmens V, Mitry E, et al. Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013. Ann Oncol. 2015;26(3):463–76.

4. Ades S. Adjuvant chemotherapy for colon cancer in the elderly: moving from evidence to practice. Oncology (Williston Park). 2009;23(2):162–7.

5. Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383(9927):1490–502.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synchronous multiple primary cancers involving rectal cancer and pelvic classical hodgkin lymphoma: the first case report;Frontiers in Oncology;2023-11-24

2. The prognostic value of tumour-infiltrating lymphocytes, programmed cell death protein-1 and programmed cell death ligand-1 in Stage I–III triple-negative breast cancer;British Journal of Cancer;2023-03-25

3. Osteopontin in Cancer: Mechanisms and Therapeutic Targets;International Journal of Translational Medicine;2022-08-19

4. Overexpression of Metastasis-Associated in Colon Cancer 1-Antisense RNA 1 (MACC1-AS1) in Bone Marrow Mesenchymal Stem Cells (BMSCs) Inhibits miR-145-5P and Promotes Chemotherapy Resistance of Colorectal Cancer;Journal of Biomaterials and Tissue Engineering;2022-08-01

5. Evaluation of serum osteopontin and its relation with other biomarkers of prostate cancer in Iraqi patients;International Conference of Chemistry and Petrochemical Techniques (ICCPT);2022